Oxelumab: Difference between revisions
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Ethmostigmus (talk | contribs) m Rescued dead link, Template:One source |
||
| (14 intermediate revisions by 10 users not shown) | |||
| Line 1: | Line 1: | ||
{{One source|find=Oxelumab|date=January 2024}} |
|||
{{Short description|Monoclonal antibody}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
| verifiedrevid = 458269218 |
|||
| type = mab |
| type = mab |
||
| image = |
| image = |
||
| Line 12: | Line 17: | ||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category= |
| pregnancy_category= |
||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> |
||
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> |
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> |
||
| Line 23: | Line 28: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
| CAS_number |
| CAS_number = 1186098-83-8 |
||
| ⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 67GFR7JCMN |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ⚫ | |||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| PubChem = |
| PubChem = |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = |
|||
| C=6424 | H=9920 | N=1704 | O=2014 | S=42 |
| DrugBank = |
||
| C=6424 | H=9920 | N=1704 | O=2014 | S=42 |
|||
| molecular_weight = 144.6 kDa |
|||
}} |
}} |
||
'''Oxelumab''' is a human monoclonal antibody designed for the treatment of [[asthma]].<ref>{{cite web|title=Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab|publisher=[[American Medical Association]]|url=http://www.ama-assn.org/resources/doc/usan/oxelumab.pdf}}</ref> |
'''Oxelumab''' is a human monoclonal antibody designed for the treatment of [[asthma]].<ref>{{cite web|title=Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab|publisher=[[American Medical Association]]|url=http://www.ama-assn.org/resources/doc/usan/oxelumab.pdf |archive-url=https://web.archive.org/web/20130512162542/http://www.ama-assn.org/resources/doc/usan/oxelumab.pdf |archive-date=12 May 2013 |url-status=dead}}</ref> |
||
Oxelumab was developed by [[Genentech]] and co-developed by [[Hoffmann-La Roche|Roche]]. |
Oxelumab was developed by [[Genentech]] and co-developed by [[Hoffmann-La Roche|Roche]]. |
||
| Line 42: | Line 51: | ||
{{monoclonals for immune system}} |
{{monoclonals for immune system}} |
||
[[Category:Hoffmann-La Roche]] |
[[Category:Drugs developed by Hoffmann-La Roche]] |
||
[[Category:Drugs developed by Genentech]] |
|||
[[Category:Experimental drugs]] |
|||
{{monoclonal-antibody-stub}} |
{{monoclonal-antibody-stub}} |
||